Explore the intricacies of the FDA's new classification for DNA-based tests measuring minimal residual disease in hematological malignancies. Learn how the shift to Class II with special controls impacts safety, effectiveness, and patient access, reducing regulatory...
Healthcare and Public Health
Showing 37–45 of 228 resultsSorted by latest
-
Modernizing the H-1B Program: Key Changes and Compliance
$199.99 -
SSA FOIA Regulations: Accessibility and Compliance
$49.99 -
Payments for Brain Injuries Under the HAVANA Act: What You Need to Know
$19.99 -
Health Data, Technology, and Interoperability: Protecting Care Access
$129.99 -
SNAP Final Rule Compliance Course
$129.99 -
Comprehensive Training on the Final Rule for Select Agents and Toxins
$49.99 -
Compliance with the Agricultural Bioterrorism Protection Act
$49.99 -
Protection of Stratospheric Ozone: Understanding EPA’s Determination 39
$49.99 -
Telehealth Grant Program for Veterans
$49.99